This is the authors' abstract. We don't add key points for this paper.
The increasing demand for nuclear power and radiotherapy has expanded potential avenues for human exposure to whole-body irradiation (WBI), underscoring the need to understand its impact on immune cells. While prior studies have explored radiation-induced disruptions in immune homeostasis, the direct effect of WBI on pre-existing memory CD4 T cells remains elusive. Using T cell receptor transgenic CD4 T cell chimeric mice infected with lymphocytic choriomeningitis virus-Armstrong, we demonstrate that a sublethal WBI dose (5 Gy) causes a significant and persistent reduction in the numbers of memory CD4 T cells for at least 30 d post-WBI. At 8 d post-WBI, memory CD4 T cells exhibited an increased frequency of Ly6C+ T helper 1 cells and a decreased frequency of PSGL1+Ly6C- central memory cells in the spleen compared with mock-irradiated (0 Gy) control mice. These subset imbalances were no longer detectable by 30 d post-WBI. However, surviving memory CD4 T cells exhibited intrinsic functional impairments, including reduced production of the proinflammatory cytokines IFNγ, TNFα, and IL-2 upon ex vivo stimulation with the gp61-80 peptide. Furthermore, irradiated T cell receptor transgenic memory CD4 T cells exhibited defective secondary expansion upon pathogen re-encounter in unmanipulated hosts. Finally, the irradiated primary memory CD4 T cells exhibited poor protection potential, as they were unable to clear the pathogen upon re-exposure as effectively as their 0 Gy counterpart. In summary, sublethal WBI impairs the kinetics, subset composition, and function of memory CD4 T cells, ultimately compromising their ability to mount effective recall responses to clear the infection.
No takes yet. Share an insight, caveat, or question.
Kannan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: